Biolase Technology Inc.
Dental laser supplier !%Biolase Technology Inc.%! of Irvine, Calif., has been issued US Patent No. 7,997,279, titled “Methods for Treating Eye Conditions,” by the US Patent and Trademark Office. The patent strengthens the company’s expansion into the treatment of eye conditions, including presbyopia. It expands Patent No. 7,665,467, with broad claims covering the use of laser technology for treating various eye conditions.
Biolase also has formed a new entity, Oculase Inc., a Delaware-based corporation that will own and develop Biolase’s ophthalmic assets and technologies.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024